FeesSafety
Pluang+

Research Solutions reports 11.5% YoY B2B ARR growth, $22.5M total ARR, and improved gross margin in Q1 2027.

Company Fundamentals
16 Nov 2026, 23:05 WIB
PRNewsWire
View Source
Bullish
Research Solutions reports 11.5% YoY B2B ARR growth, $22.5M total ARR, and improved gross margin in Q1 2027.

Research Solutions announced an 11.5% year-over-year increase in B2B annual recurring revenue (ARR) to $16.5 million, contributing to a total ARR of $22.5 million for Q1 2027. Despite a slight revenue decline to $11.9 million, platform revenue grew 3.7%, driving a 300 basis point improvement in gross margin to 53.6%. The company reported net income of $765,000 and adjusted EBITDA of $1.0 million, reflecting ongoing shifts toward higher-margin, recurring revenue models and investments in AI-powered research tools. These results position Research Solutions for continued growth through innovation and expanded customer engagement.

Research Solutions reported an 11.5% year-over-year increase in B2B annual recurring revenue to $16.5 million in Q1 2027. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 17, 2026 03:21 WIB: out of 150 priced US tech stocks, 26 rose and 123 fell. Notable movers include VNET at USD 2.64 with a -11.41% change, AEHR at USD 50.88 down 10.70%, and AXTI at USD 37.86 down 9.51%.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App